letters & comments

NHC Comments on HELP Committee Request for Information on Lowering Health Care Costs

03/20/2019

Read More

NHC Comments on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2020

02/19/2019

Read More

NHC Comments on ICER Unsupported Price Increase Assessment

02/13/2019

Read More

NHC Comments on Framework for a Real-World Evidence Program; Availability

02/07/2019

Read More

NHC Comments on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses

01/25/2019

Read More

NHC Comments on Patient Engagement in Medical Device Clinical Trials Discussion Document

01/08/2019

Read More

NHC Comments on Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs

12/31/2018

Read More

NHC Letter on State Relief and Empowerment Waivers

12/24/2018

Read More

NHC Comments on Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments

12/14/2018

Read More
1 2 3 4 5